Clinical trial
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS: a Prospective Cohort Study
NCT06317896 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS: a Prospective Cohort Study
- Lead sponsor
- Zhujiang Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 82 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
circulating tumor cell, hepatocellular carcinoma, recurrence, surgery